Crowdonomics
ClearLight Biotechnologies, Inc.

Reg A+ · Equity · Nov 2021

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $240K max
0% of ceiling
Investors
—
—
Estimated pre-money
$13.6M
—

Financials disclosed in this offering

FY2020 · hover for source
$30K
−$680K
FY2020
RevenueNet income
Metric
FY2020
Income statement
Revenue
$29,874
Cost of goods sold
$157,760
Gross margin
-428%
Net income
-$680,461
Balance sheet
Cash
$718,333
Accounts receivable
$17,595
Total assets
$2,072,588
Long-term debt
$0
Total liabilities
$500,080
Other
Headcount
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Dec 2, 2021
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$13.6M
Price / share$12.00
Shares offered20,000

Estimated, not stated: $12.00 × 1,134,331 securities outstanding.

Offering details

Target—
Max$240,000
Min investment—
OpenedNov 19, 2021
Deadline—
Days active1,786

Links & provenance

Source: SEC EDGAR
0001062993-21-011161
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.